In 2012, Lin et al. evaluated the effects of SCFA administration in mice with the premise being that SCFAs regulate gut hormones via free fatty acid receptors 2 (FFAR2) and 3 (FFAR3) ultimately protecting against diet-induced obesity and the development of insulin resistance (7). Here, FFAR2 is linked to obesity disorder.